RU2015148217A - PHARMACEUTICAL DRUG FOR TREATMENT OF ARTHROLOGICAL DISEASES - Google Patents

PHARMACEUTICAL DRUG FOR TREATMENT OF ARTHROLOGICAL DISEASES Download PDF

Info

Publication number
RU2015148217A
RU2015148217A RU2015148217A RU2015148217A RU2015148217A RU 2015148217 A RU2015148217 A RU 2015148217A RU 2015148217 A RU2015148217 A RU 2015148217A RU 2015148217 A RU2015148217 A RU 2015148217A RU 2015148217 A RU2015148217 A RU 2015148217A
Authority
RU
Russia
Prior art keywords
treatment
pharmaceutical drug
chondroitin sulfate
arthrological
diseases
Prior art date
Application number
RU2015148217A
Other languages
Russian (ru)
Other versions
RU2015148217A3 (en
RU2743274C9 (en
RU2743274C2 (en
Inventor
Владислав Николаевич Шестаков
Людмила Васильевна Персанова
Original Assignee
Общество с ограниченной ответственностью "ДИАМЕД-фарма"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество с ограниченной ответственностью "ДИАМЕД-фарма" filed Critical Общество с ограниченной ответственностью "ДИАМЕД-фарма"
Priority to RU2015148217A priority Critical patent/RU2743274C9/en
Priority to EA201800236A priority patent/EA201800236A1/en
Priority to UAA201812671U priority patent/UA149009U/en
Priority to PCT/RU2016/000757 priority patent/WO2017082771A1/en
Publication of RU2015148217A publication Critical patent/RU2015148217A/en
Publication of RU2015148217A3 publication Critical patent/RU2015148217A3/ru
Application granted granted Critical
Publication of RU2743274C2 publication Critical patent/RU2743274C2/en
Publication of RU2743274C9 publication Critical patent/RU2743274C9/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Claims (3)

1. Средство для лечения артрологических заболеваний, включающее Na-соль хондроитина сульфата, отличающееся тем, что Na-соль хондроитина сульфата содержится в виде лиофилизованного порошка и препарат не содержит консерванта, при следующем соотношении компонентов:1. An agent for the treatment of arthrological diseases, including the Na-salt of chondroitin sulfate, characterized in that the Na-salt of chondroitin sulfate is contained in the form of lyophilized powder and the preparation does not contain a preservative, in the following ratio of components: Лиофилизованный порошок Хондроитина сульфата 95-120 мг, в том числе Хондроитина сульфата 9,0-11,5 мас. %Lyophilized powder of Chondroitin sulfate 95-120 mg, including Chondroitin sulfate 9.0-11.5 wt. % 2. Способ по п. 1, отличающийся тем, что содержание в ампуле хондроитина сульфата составляет 9,0-11,5 мас. %.2. The method according to p. 1, characterized in that the content in the ampoule of chondroitin sulfate is 9.0-11.5 wt. %
RU2015148217A 2015-11-10 2015-11-10 Pharmaceutical preparation for treatment of arthrological diseases RU2743274C9 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
RU2015148217A RU2743274C9 (en) 2015-11-10 2015-11-10 Pharmaceutical preparation for treatment of arthrological diseases
EA201800236A EA201800236A1 (en) 2015-11-10 2016-11-09 PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF ARTHROLOGICAL DISEASES
UAA201812671U UA149009U (en) 2015-11-10 2016-11-09 Pharmaceutical preparation for treating arthrological diseases
PCT/RU2016/000757 WO2017082771A1 (en) 2015-11-10 2016-11-09 Pharmaceutical preparation for treating arthrological diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2015148217A RU2743274C9 (en) 2015-11-10 2015-11-10 Pharmaceutical preparation for treatment of arthrological diseases

Publications (4)

Publication Number Publication Date
RU2015148217A true RU2015148217A (en) 2017-05-15
RU2015148217A3 RU2015148217A3 (en) 2018-10-12
RU2743274C2 RU2743274C2 (en) 2021-02-16
RU2743274C9 RU2743274C9 (en) 2021-04-08

Family

ID=58695895

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2015148217A RU2743274C9 (en) 2015-11-10 2015-11-10 Pharmaceutical preparation for treatment of arthrological diseases

Country Status (4)

Country Link
EA (1) EA201800236A1 (en)
RU (1) RU2743274C9 (en)
UA (1) UA149009U (en)
WO (1) WO2017082771A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2021812C1 (en) * 1992-04-13 1994-10-30 Всесоюзный научно-исследовательский институт технологии кровезаменителей и гормональных препаратов Agent for arthrological diseases treatment
RU2080857C1 (en) * 1994-10-07 1997-06-10 Научно-производственное объединение "Иммунопрепарат" Method of preparing the preparation chondroitin sulfate injection form
CA2217360A1 (en) * 1995-04-04 1996-10-10 Otsuka Pharmaceutical Co., Ltd. Package holding a procaterol hydrochloride aqueous solution formulation, and a procaterol hydrochloride aqueous solution formulation
CN101215339A (en) * 2008-01-11 2008-07-09 张国志 Method for purifying sodium chondroitin sulfate
RU2458693C1 (en) * 2011-07-28 2012-08-20 Валентин Антонович Виноградов Lyophilised pharmaceutical composition for preparing solution for injections for treating degenerate-dystrophic locomotor diseases and method for preparing it
RU2545689C2 (en) * 2013-04-09 2015-04-10 Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Министерства здравоохранения Российской Федерации Method for preparing injectable dosage form of high-purity drug preparation for treating degenerative diseases of locomotor apparatus

Also Published As

Publication number Publication date
WO2017082771A1 (en) 2017-05-18
RU2015148217A3 (en) 2018-10-12
RU2743274C9 (en) 2021-04-08
RU2743274C2 (en) 2021-02-16
UA149009U (en) 2021-10-13
EA201800236A1 (en) 2018-07-31

Similar Documents

Publication Publication Date Title
EA201892395A1 (en) DRUG COMPOSITIONS OF LSD1 INHIBITOR
NZ734516A (en) Pharmaceutical compositions comprising n-(3,5-dimethoxyphenyl)-n’-(1-methylethyl)-n-[3-(1-methyl-1h-pyrazol-4-yl)quinoxalin-6-yl]ethane-1,2-diamine
NZ712270A (en) Pharmaceutical composition of s-ketamine hydrochloride
PH12015502539A1 (en) Cenicriviroc compositions and methods of making and using the same
WO2016190683A8 (en) Composition for preventing and treating muscle diseases or improving muscular function, containing platycodon grandiflorum extract
EA201691918A1 (en) PHARMACEUTICAL COMPOSITIONS OF KINAZ INHIBITOR KINAZ OF THE RAF FAMILY, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE
RU2019139886A (en) THERAPEUTIC AGAINST DYSFUNCTION OF MEIBOMIUM GLANDS
EA201691490A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING BRINZOLAMIDE
FI3666258T3 (en) Method of treating prader-willi syndrome
MX2018000084A (en) Pharmaceutical composition containing amlodipine, valsartan, and rosuvastatin.
MD3482754T2 (en) Pharmaceutical compositions and uses directed to lysosomal storage disorders
PH12017500320B1 (en) Pharmaceutical composition comprising gold-containing agent for preventing or treating liver fibrosis or liver cirrhosis
RU2016133688A (en) Compositions containing Curcuma Longa and Echinacea angustifolia extracts that are useful in reducing peripheral inflammation and pain
RU2019110980A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING A 15-HEPC AND METHODS FOR TREATING ASTHMA AND LUNG DISEASES WITH THEIR APPLICATION
MY200278A (en) Methods of improving exercise capacity in fontan patients using udenafil compositions
WO2016153262A3 (en) Pharmaceutical composition comprising the extract of platycodon grandiflorum enhanced effective saponin contents for treatment of rheumatoid arthritis
RU2012136775A (en) METHOD AND MEANS FOR INCREASING ADAPTIVE POSSIBILITIES OF AN ATHLETES ORGANISM DURING THE TRAINING PROCESS
RU2015148217A (en) PHARMACEUTICAL DRUG FOR TREATMENT OF ARTHROLOGICAL DISEASES
PH12019500024A1 (en) Pharmaceutical compositions
RU2013124416A (en) DIINDOLYLMETHANE MEDICINAL PRODUCT AND ITS APPLICATION FOR TREATMENT OF INFLUENZA AND RESPIRATORY VIRAL INFECTIONS
WO2016114621A3 (en) Composition for prevention or treatment of metabolic bone diseases comprising combined extract of schisandra chinesis, eucommiae cortex and lycium chinense as active ingredient
MX2015012666A (en) Complex preparation including valsartan and rosuvastatin calcium and manufacturing method therefor.
MX2018008443A (en) Pharmaceutical composition comprising nebivolol with improved dissolution rate.
MX2018001528A (en) Pharmaceutical composition comprising sumatripan for treating migraine.
RU2015122882A (en) PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF DIABETIC ANGIOPATHIES AND NEUROPATHIES

Legal Events

Date Code Title Description
HE9A Changing address for correspondence with an applicant
TH4A Reissue of patent specification